GB2064 clinical trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis

This study is testing a new medicine called GB2064 for people with myelofibrosis, a rare blood cancer. It will check if the medicine is safe, how the body handles it, and if it has any effects on the disease over nine months.